Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03043261

Acronym

EMERGE

Enrollment

Registered

2017-02-06

Start date

2018-01-29

Completion date

2018-04-07

Last updated

2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Keywords

CHF

Brief summary

EMERGE is a PI-initiated feasibility study that aims to evaluate the accessibility, usability, effectiveness and relevance of an integrated psycho-behavioral intervention on heart failure patients in order to increase support, outreach and general well-being of these patients following hospitalization due to heart failure exacerbation.

Interventions

BEHAVIORALWilliams LifeSkills

Online multi-media interactive training modules which address 10 core skills to improve coping, stress management and interpersonal relationships.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult male and female patients, age ≥ 18 hospitalized at Duke inpatient service because of heart failure * NYHA Class ≥ II

Exclusion criteria

* Significant cognitive impairment, indicated as a mini-mental state exam (MMSE) total score of 23 or lower * Lack of convenient internet access outside of hospital * Alcohol or other drug dependence/abuse within past 90 days as evaluated by review of medical record and patient interview (SCID) * Severe physical disability (visual, sensory or motor) that may interfere with study participation (assessment, online interactive learning) * History or presence of psychoses, bipolar disorder, and/or severe personality disorders as evaluated by review of medical record and patient interview (SCID) * Life-threatening co-morbidity with the likelihood of 50% mortality in one year * Active suicidal ideations * Female patients of childbearing potential * Treatment with electroconvulsive therapy or transcranial magnetic stimulation within past 90 days * Uncorrected hypothyroidism or hyperthyroidism

Design outcomes

Primary

Measure	Time frame	Description
Subject retention	6 month	Percentage of subjects who complete the intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026